Forever young
Sydney healthcare startup Eucalyptus is the latest company to chase a piece of the growing longevity market with a $995-a-month program called Compound.
A few weeks ago a photo of the Kardashians (Kim, Kris and Khloe) posing next to a pale tech founder and a burly neuroscientist popped up on X.
The odd and widely shared shot signalled something significant: the reverse-ageing trend those two dinner companions have championed has well and truly gone mainstream.
Bryan Johnson, who shared the photo, is an American entrepreneur whose $2 million campaign to not die has led him to inject his son’s plasma, while Andrew Huberman is a divisive professor turned podcaster who encourages millions of listeners to maximise their productivity and health.
Interest in longevity and peak performance is intense, so perhaps it is unsurprising that there are widespread attempts to monetise it. And as Capital Brief profiled today, Australia’s most prolific health startup Eucalyptus is now getting in on the action with its latest venture, Compound.
